EMBC vs XRAY · P/E 12, rev $1.08B vs rev $1.78B
Embecta Corp (EMBC) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Embecta Corp (EMBC) is a medical instruments & supplies company listed on US.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported EMBC revenue for 2025-09-30 was $1.08B. Net income was $95.4M. Revenue was down 3.8% from 2024-09-30 to 2025-09-30. EMBC currently screens at market cap $609.6M and trailing P/E 11.7.
Latest reported XRAY revenue for 2026-06-30 was $1.78B. Net income was $27.0M. XRAY currently screens at market cap $2.01B.
EMBC currently screens at market cap $609.6M and trailing P/E 11.7. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the EMBC and XRAY stock pages for the full models.
Not investment advice.